Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
clinical trials
drug prices
2
×
gene therapy
life sciences
national
national blog main
national top stories
new york top stories
novartis
san francisco top stories
zolgensma
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
billy dunn
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
What
drug
new
2
×
approval
approved
atrophy
bio
biogen’s
biopharmaceutical
companies
convo
daily
earlier
evrysdi
failures
fda
friday
green
home
intended
lights
liquid
littered
medicine
muscular
nash
news
oral
patients
price
remains
risdiplam
road
roche
roundup
spinal
strategy
talk
therapy
Language
unset
Current search:
biogen
×
new
×
" drug prices "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
